Updated Jul 16, 2026
SHAH MAHENDRA is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $47K.

| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-10-07 | VRNA | Verona Pharma plc | D — Derivative transaction | 72.0K | — | |
| 2025-10-07 | VRNA | Verona Pharma plc | M — Option exercise | 72.0K | — | |
| 2025-10-07 | VRNA | Verona Pharma plc | D — Derivative transaction | 93.5K | — | |
| 2025-08-01 | VRNA | Verona Pharma plc | S — Open-market sale | 3.6K | $13.14 | $47K |
| 2025-08-01 | VRNA | Verona Pharma plc | M — Option exercise | 24.0K | $0.00 |
SHAH MAHENDRA is a corporate insider — currently tracked as Director. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($47K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live SHAH MAHENDRA profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.